MedTrace Logo

High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)

NCT07205523 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-10-03

No results posted yet for this study

Summary

The High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) study is the first prospective real-world cohort of hematologic diseases and transplantation in the Qinghai-Tibet Plateau. Patients undergoing hematopoietic stem cell transplantation (HSCT) at Qinghai University Affiliated Hospital, together with their donors, are systematically enrolled. The registry collects demographic, diagnostic, treatment, prognosis, and medical expense information, as well as biospecimens for future analyses. Historical data are incorporated, and prospective data collection is ongoing with long-term follow-up planned. The registry is designed as a sustainable research infrastructure to provide comprehensive data on disease incidence, treatment patterns, outcomes, and resource utilization in a high-altitude setting.

Conditions

Sponsors & Collaborators

  • Yigeng Cao,MD,PhD

    lead OTHER

Principal Investigators

  • Hui Geng · Affiliated Hospital of Qinghai University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2060-12-31
Completion
2100-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07205523 on ClinicalTrials.gov